The first serious complaint moment
Picture the quality assurance manager when a serious complaint arrives before reportability has been discussed. The team is worried about missing a deadline while also avoiding unsupported determinations.
The first move is not to declare whether the signal raises safety, compliance, reportability, equivalence, or exposure questions. The useful move is to map the event facts, source context, missing evidence, owners, and qualified-review questions.
Adverse-event triage checklist
| Checklist row | What to capture |
|---|---|
| Event facts | What happened, when, to whom, with which product, and what harm or potential harm is alleged. |
| Evidence on hand | Complaint record, service record, device history, labeling, IFU, risk file, prior events, and public-source context. |
| Jurisdiction | Which markets, manufacturer roles, importer/distributor roles, and reporting frameworks may need qualified review. |
| Owner | Complaint, RA/QA, regulatory, clinical, legal, service, risk, CAPA, or leadership owner for each open item. |
| Boundary | Which reportability, recall, CAPA, safety, clinical, or compliance decisions remain open. |
What good looks like
A useful adverse-event triage packet does not say whether the event is reportable. It shows the facts reviewed, the evidence missing, the owner map, the source context, and the qualified-review questions.
If the first pass slows the team down just enough to avoid guessing, it has done useful work. The next discussion can focus on evidence and owners instead of memory and panic.
Source ledger
What it can tell you
Public FDA recall and early-alert context that can help teams compare outside signals and source families.
What it cannot decide
Whether one complaint is reportable, whether a correction or removal is required, or whether a recall decision applies.
What it can tell you
Canadian public recall and safety-alert records that may be relevant to a multi-market signal review.
What it cannot decide
Whether one event triggers Canadian reporting, recall, complaint, or importer/distributor obligations.
What it can tell you
European medical-device sector context that can frame EU vigilance and postmarket evidence questions.
What it cannot decide
Whether one adverse event is reportable, whether a manufacturer has met vigilance duties, or whether a clinical or safety conclusion is supported.
Frequently asked questions
Does this checklist decide whether an adverse event must be reported?
No. It organizes facts and review questions. Reportability, timing, recall, CAPA, risk, clinical, safety, and compliance decisions remain with qualified reviewers.
What should be captured before the reportability discussion?
Capture event facts, product identifiers, alleged harm, missing evidence, source context, jurisdiction signals, owner assignments, and open qualified-review decisions.
Need an adverse-event triage packet before the next review call?
Send the event trigger, product family, and current evidence list. We can scope a source-backed triage checklist for qualified review.
Reader feedback
Useful pages should feed the next topic choices. Leave a signal or a short comment.